HH-5709

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameHH-5709
Drug Alias NameHH-5709
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRibosomal protein S6 kinase alpha-2 inhibitors
TargetsRibosomal protein S6 kinase alpha-2
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNagoya University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNagoya University
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A